Embolx Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 13

Embolx General Information

Description

Provider of balloon occlusion microcatheters designed to treat cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The company's microcatheters sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues, enabling doctors to improve treatment for a variety of conditions and improves killing the tumor.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • 530 Lakeside Drive
  • Suite 200
  • Sunnyvale, CA 94085
  • United States
+1 (408) 000-0000

Embolx Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Embolx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 13-Apr-2020 000.00 Completed
8. Later Stage VC 29-Jan-2019 00.00 000.00 Completed Generating Revenue
7. Early Stage VC 00.00 Completed Generating Revenue
6. Grant 06-Apr-2018 000 00.00 Completed Generating Revenue
5. Early Stage VC (Series B) 01-Nov-2017 00.00 00.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A2) 15-Jun-2016 00.00 00.000 000.00 Completed Generating Revenue
3. Grant 01-Jan-2015 00000 00.000 Completed Generating Revenue
2. Early Stage VC (Series A1) 30-Nov-2014 $1.5M $1.75M 000 Completed Generating Revenue
1. Early Stage VC (Series A) 09-May-2014 $250K $250K Completed Generating Revenue
To view Embolx’s complete valuation and funding history, request access »

Embolx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00 000.00 000.00 00 000.00 00.000
Series A2 000,000 00 000.00 000.00 00 000.00 00.000
Series A1 404,836 8% $3.74 $3.74 1x $3.74 17.61%
Series A 151,874 8% $3.29 $3.29 1x $3.29 6.61%
To view Embolx’s complete cap table history, request access »

Embolx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of balloon occlusion microcatheters designed to treat cancerous tumors, benign prostatic hyperplasia and uterin
Surgical Devices
Sunnyvale, CA
9 As of 2020
000.00
000000000 - 000.00

00000000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000000 0000000
Westminster, CO
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Embolx Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 0000 0000 Venture Capital-Backed Westminster, CO 00 000.00 00000000000 000.00
To view Embolx’s complete competitors history, request access »

Embolx Executive Team (6)

Name Title Board Seat Contact Info
Michael Allen Chief Executive Officer, President & Board Member
Greg Halstead Director, Engineering & Operations
John Layton Director, Marketing
Michael Lin Director of Finance
Ben Felipe Director of Sales
You’re viewing 5 of 6 executive team members. Get the full list »

Embolx Board Members (6)

Name Representing Role Since
Frank Grillo Self Board Member & Secretary 000 0000
Michael Allen Embolx Chief Executive Officer, President & Board Member 000 0000
Norm Gitis Ph.D Band of Angels Chairman 000 0000
Paul Rogan Self Board Member 000 0000
Robert de Neve Embolx Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Embolx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Embolx Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Acorn Campus Taiwan Venture Capital Minority 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
VI Ventures Venture Capital Minority 000 0000 000000 0
Acorn Campus Ventures Venture Capital Minority 000 0000 000000 0
Sood Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »